Standout Papers

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or afliberc... 2014 2026 2018 2022 274
  1. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD (2014)
    Robert L. Avery, Alessandro Castellarin et al. British Journal of Ophthalmology

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
1 intermediate paper

Works of Jennifer Visich being referenced

A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis
2021
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
2014 Standout

Author Peers

Author Last Decade Papers Cites
Jennifer Visich 451 189 178 295 275 34 1.1k
Shizuyo Tsujimura 221 232 84 106 281 32 948
Gráinne Murphy 235 150 89 117 580 37 1.4k
Tsukasa Takemura 180 71 122 58 202 55 1.1k
Leonor Barile-Fabris 198 68 141 62 393 26 1.1k
Sara M. Federico 63 336 54 95 122 61 934
S.L. Tucker 330 555 156 54 52 39 1.4k
Anna Butturini 80 294 428 61 114 48 1.1k
Francisco Caeiro 187 93 110 41 510 32 1.1k
Eva Pérez‐Pampín 157 126 170 26 323 63 1.1k
Ernest Marshall 74 472 71 215 209 41 910

All Works

Loading papers...

Rankless by CCL
2026